€10M Series A Boosts Cancer Immunotherapy Hitting Tumor Sugar Coating
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
22/04/2020 - 3 minutes
News and Trends
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
21/04/2020 - 3 minutes
French Biotech Licenses Microbiome Therapeutic to Treat Mood Disorders
The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific…
17/04/2020 - 3 minutes
Is New Enzyme Technology Key to Solving Society’s Plastic Problem?
A new type of enzyme developed by the French company Carbios can break down more…
17/04/2020 - 4 minutes
Irish Biotech Raises €18M to Develop Non-Viral Cell Therapy Technology
The Irish company Avectas has closed a Series C round to develop cell therapies that…
16/04/2020 - 2 minutes
Healx Deploys AI Drug Discovery Technology Against Rare Nerve Disease
The AI-driven drug repurposing company Healx has teamed up with the global Children’s Tumor Foundation…
15/04/2020 - 3 minutes
Coronavirus Pandemic Bites into European Cancer Research
The UK funder Cancer Research UK and Swedish oncology biotech Alligator Bioscience have independently announced…
10/04/2020 - 4 minutes
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
09/04/2020 - 4 minutes
Evotec Makes Move into Gene Therapy with Takeda Deal
German biotech giant Evotec has moved into gene therapy and partnered with Takeda to develop…
08/04/2020 - 3 minutes
UK Biotech’s Arthritis Drug Enters Study in Coronavirus Patients
The UK company Izana Bioscience is freely providing its phase III-ready anti-inflammatory antibody namilumab in…
06/04/2020 - 2 minutes
UK-US Initiative to Screen Drugs Using AI for Coronavirus Treatments
The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection…
03/04/2020 - 4 minutes
Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M
Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…
03/04/2020 - 2 minutes
